Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of a Human Monoclonal Antibody for Inhalational Anthrax
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Functional Role for GPR55 in the periaqueductal gray
Broadly protective (universal) virus-like particle (VLP) based influenza vaccine
Analysis of Kinase and Phosphatase Signaling Complexes
Cocaine Abuse Prevention Project
Epstein-Barr Virus and Nasopharyngeal Carcinoma
Recently added grants:
Does the Addition of Cognitive Remediation to Coordinated Specialty Care Services Improve Functional Outcome?
A mobile phone intervention using a relational human talking Avatar to promote multiple stages of the HIV Care Continuum in African American MSM
Alcohol, bacterial dysbiosis, and inflammation during colitis
ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration
Oxidation of K+ channels mediates an amyloidogenic pathway common to Alzheimer's disease and TBI
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200700033C-2-0-1
Application #
7567309
Study Section
Project Start
2007-09-28
Project End
2011-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
Development of a Human Monoclonal Antibody for Inhalational Anthrax
/ Pharmathene, Inc.
$1,998,109
NIH 2007
N01 AI
Development of a Human Monoclonal Antibody for Inhalational Anthrax
/
Comments
Be the first to comment on this grant